Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.310
-0.030 (-2.24%)
At close: Oct 29, 2024, 4:00 PM
1.300
-0.010 (-0.76%)
After-hours: Oct 29, 2024, 5:32 PM EDT
Immunic Employees
Immunic had 77 employees as of December 31, 2023. The number of employees increased by 11 or 16.67% compared to the previous year.
Employees
77
Change (1Y)
11
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,237,727
Market Cap
118.00M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nutex Health | 800 |
| Seres Therapeutics | 233 |
| Veru Inc. | 189 |
| Seer, Inc. | 147 |
| Zomedica | 144 |
| Myomo | 106 |
| Invivyd | 95 |
| Journey Medical | 41 |
IMUX News
- 19 hours ago - Immunic to Participate in Industry, Scientific and Investor Conferences in November - PRNewsWire
- 7 days ago - Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis - PRNewsWire
- 5 weeks ago - Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis - PRNewsWire
- 7 weeks ago - Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome - PRNewsWire
- 2 months ago - Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September - PRNewsWire
- 2 months ago - Immunic, Inc. (IMUX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update - PRNewsWire